AMANDA WINTER: Open Payments
NPI 1518487917 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 59 payments from 12 companies in 2025. Trend: 2023 $81 · 2024 $73 · 2025 $1,281
Food & beverage: $1,281
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 31 | $762 |
| GlaxoSmithKline, LLC. | 5 | $100 |
| Insmed, Inc. | 4 | $71 |
| GENZYME CORPORATION | 4 | $70 |
| Philips North America LLC | 2 | $61 |
| Viatris Specialty LLC | 2 | $49 |
| Lilly USA, LLC | 3 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Grifols USA, LLC | 2 | $30 |
| Electromed, Inc. | 2 | $21 |
Products named: AIRSUPRA, BREZTRI, DUPIXENT, TRELEGY ELLIPTA, Arikayce, Encore, YUPELRI, ZEPBOUND.
Industry payments across TN — which companies pay providers there.
